CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Arcturus Therapeutics Holdings Inc. - ARCT CFD

15.37
2.06%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.09
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 15.04
开盘价* 14.51
1 年变化* -58.88%
日范围* 14.51 - 15.59
52 周范围 11.70-31.41
平均交易量(10 天) 318.14K
平均交易量(3 个月) 6.86M
市值 400.04M
市盈率 -100.00K
流通股 26.49M
收入 51.50M
EPS -5.56
股息(收益率 %) N/A
贝塔 2.56
下一个财报发布日期 Mar 28, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Jun 29, 2022 15.37 0.54 3.64% 14.83 15.60 14.44
Jun 28, 2022 15.04 -0.93 -5.82% 15.97 16.21 14.77
Jun 27, 2022 16.14 0.75 4.87% 15.39 16.39 15.22
Jun 24, 2022 15.87 -0.21 -1.31% 16.08 16.42 14.99
Jun 23, 2022 15.93 0.85 5.64% 15.08 16.08 14.88
Jun 22, 2022 15.36 1.52 10.98% 13.84 16.06 13.84
Jun 21, 2022 14.51 0.68 4.92% 13.83 15.47 13.83
Jun 17, 2022 13.39 0.89 7.12% 12.50 14.16 12.50
Jun 16, 2022 12.21 -0.26 -2.09% 12.47 12.63 11.65
Jun 15, 2022 13.22 0.38 2.96% 12.84 13.45 12.27
Jun 14, 2022 12.85 -0.43 -3.24% 13.28 13.28 12.31
Jun 13, 2022 13.13 -1.10 -7.73% 14.23 14.23 12.47
Jun 10, 2022 15.03 -1.42 -8.63% 16.45 16.75 14.66
Jun 9, 2022 17.07 -1.92 -10.11% 18.99 18.99 16.99
Jun 8, 2022 19.40 0.14 0.73% 19.26 20.15 19.17
Jun 7, 2022 19.43 1.48 8.25% 17.95 19.56 17.74
Jun 6, 2022 18.46 -1.51 -7.56% 19.97 20.59 17.57
Jun 3, 2022 19.89 1.99 11.12% 17.90 19.94 17.90
Jun 2, 2022 18.77 1.00 5.63% 17.77 19.11 17.77
Jun 1, 2022 18.37 -0.88 -4.57% 19.25 20.51 17.93

Arcturus Therapeutics Holdings Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 12.359 9.539 20.789 15.753 12.998
收入 12.359 9.539 20.789 15.753 12.998
总营业费用 215.211 81.063 46.302 37.564 23.49
销售/一般/行政费用,总计 41.451 23.217 12.662 20.582 7.572
研究与开发 173.76 57.846 33.64 16.982 15.918
营业收入 -202.852 -71.524 -25.513 -21.811 -10.492
利息收入(费用),非经营净值 -0.822 -0.624 -0.478 0.026 -0.061
其他,净值 0 -0.348
税前净收入 -203.674 -72.148 -25.991 -21.785 -10.901
税后净收入 -203.674 -72.148 -25.991 -21.785 -10.902
未计算非常项目前的净收益 -203.674 -72.148 -25.991 -21.785 -10.902
净收入 -203.674 -72.148 -25.991 -21.785 -10.902
普通股股东可获收益 (不含非经常性项目) -203.674 -72.148 -25.991 -21.785 -10.902
普通股股东可获收益 (含非經常性項目) -203.674 -72.148 -25.991 -21.785 -10.902
摊薄净收入 -203.674 -72.148 -25.991 -21.785 -10.902
摊薄后加权平均股 26.317 20.305 12.069 10.069 3.087
扣除特别项目的每股摊薄盈利 -7.73926 -3.55321 -2.15353 -2.16357 -3.53158
每股正常摊薄盈利 -7.73926 -3.55321 -2.15353 -2.16357 -3.53158
非常规项目总计 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 5.244 5.794 2.437 2.001 2.127
收入 5.244 5.794 2.437 2.001 2.127
总营业费用 55.623 43.439 56.258 55.721 59.793
销售/一般/行政费用,总计 10.73 10.806 10.86 10.042 9.743
研究与开发 44.893 32.633 45.398 45.679 50.05
营业收入 -50.379 -37.645 -53.821 -53.72 -57.666
利息收入(费用),非经营净值 -0.79 -1.018 -0.263 -0.861 1.32
税前净收入 -51.169 -38.663 -54.084 -54.581 -56.346
税后净收入 -51.169 -38.663 -54.084 -54.581 -56.346
未计算非常项目前的净收益 -51.169 -38.663 -54.084 -54.581 -56.346
净收入 -51.169 -38.663 -54.084 -54.581 -56.346
普通股股东可获收益 (不含非经常性项目) -51.169 -38.663 -54.084 -54.581 -56.346
普通股股东可获收益 (含非經常性項目) -51.169 -38.663 -54.084 -54.581 -56.346
摊薄净收入 -51.169 -38.663 -54.084 -54.581 -56.346
摊薄后加权平均股 26.376 26.362 26.338 26.323 26.243
扣除特别项目的每股摊薄盈利 -1.93998 -1.46662 -2.05346 -2.07351 -2.14709
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -1.93998 -1.46662 -2.05346 -2.07351 -2.14709
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 378.961 467.789 74.29 41.828 50.868
现金和短期投资 370.492 462.895 71.353 36.709 48.573
现金等价物 370.492 462.895 71.353 36.709 24.965
短期投资 0 23.608
应收账款总额,净额 3.367 2.125 2.179 4.481 0.48
Accounts Receivable - Trade, Net 3.367 2.125 2.179 4.481 0.48
Prepaid Expenses 5.102 2.769 0.758 0.638 0.704
Other Current Assets, Total 0 1.111
Total Assets 392.814 476.456 82.143 44.198 52.024
Property/Plant/Equipment, Total - Net 11.261 8.56 7.483 1.975 1.049
Property/Plant/Equipment, Total - Gross 15.517 11.623 9.664 2.016
Accumulated Depreciation, Total -4.256 -3.063 -2.181 -0.967
Other Long Term Assets, Total 2.077 0.107 0.107 0.107 0.107
Total Current Liabilities 99.537 49.521 21.324 12.577 11.04
Accounts Payable 10.058 10.774 5.793 2.398 1.79
Accrued Expenses 23.523 19.389 4.384 3.907 1.812
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 43.482 18.108 11.147 6.272 7.438
Total Liabilities 164.603 79.903 56.351 30.556 18.23
Total Long Term Debt 40.633 13.845 14.995 9.911 0
Other Liabilities, Total 24.433 16.537 20.032 8.068 7.19
Total Equity 228.211 396.553 25.792 13.642 33.794
Common Stock 0.026 0.026 0.015 0.214 0.212
Additional Paid-In Capital 575.675 540.343 97.445 58.302 56.674
Retained Earnings (Accumulated Deficit) -347.49 -143.816 -71.668 -44.874 -23.089
Other Equity, Total 0 -0.003
Total Liabilities & Shareholders’ Equity 392.814 476.456 82.143 44.198 52.024
Total Common Shares Outstanding 26.372 26.192 15.138 10.719 10.656
Long Term Investments 0.515 0.263 0.288
Long Term Debt 40.633 13.845 14.995 9.911
Current Port. of LT Debt/Capital Leases 22.474 1.25
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 327.005 378.961 420.966 438.038 469.996
现金和短期投资 319.678 370.492 413.88 433.574 466.839
现金等价物 319.678 370.492 413.88 433.574 466.839
应收账款总额,净额 3.691 3.367 2.015 2.163 2.007
Accounts Receivable - Trade, Net 3.691 3.367 2.015 2.163 2.007
Prepaid Expenses 3.636 5.102 5.071 2.301 1.15
Total Assets 341.988 392.814 434.536 448.813 481.468
Property/Plant/Equipment, Total - Net 12.775 11.261 10.826 9.748 10.117
Property/Plant/Equipment, Total - Gross 17.255 15.517 14.772 13.405 13.487
Accumulated Depreciation, Total -4.48 -4.256 -3.946 -3.657 -3.37
Long Term Investments 0.131 0.515 0.67 0.92 1.248
Other Long Term Assets, Total 2.077 2.077 2.074 0.107 0.107
Total Current Liabilities 107.306 99.537 118.239 70.769 53.333
Accounts Payable 10.014 10.058 8.265 10.084 5.597
Accrued Expenses 19.97 23.523 33.876 37.614 26.675
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 24.26 22.474 18.482 5 3.125
Other Current Liabilities, Total 53.062 43.482 57.616 18.071 17.936
Total Liabilities 157.239 164.603 175.41 143.165 128.861
Total Long Term Debt 39.235 40.633 42.345 56.309 58.147
Long Term Debt 39.235 40.633 42.345 56.309 58.147
Other Liabilities, Total 10.698 24.433 14.826 16.087 17.381
Total Equity 184.749 228.211 259.126 305.648 352.607
Common Stock 0.026 0.026 0.026 0.026 0.026
Additional Paid-In Capital 583.382 575.675 567.927 560.365 552.743
Retained Earnings (Accumulated Deficit) -398.659 -347.49 -308.827 -254.743 -200.162
Total Liabilities & Shareholders’ Equity 341.988 392.814 434.536 448.813 481.468
Total Common Shares Outstanding 26.407 26.372 26.349 26.327 26.319
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -203.674 -72.148 -25.991 -21.785 -10.902
经营活动产生的现金 -135.043 -42.861 -6.445 -20.76 -0.46
经营活动产生的现金 1.193 0.882 0.684 0.582 0.41
非现金物品 36.205 7.189 2.88 1.599 2.668
营运资金的变化 31.233 21.216 15.982 -1.156 7.364
投资活动产生的现金 -3.406 -1.742 -0.818 22.134 10.355
资本支出 -3.406 -1.742 -0.818 -1.478 -0.251
其他投资现金流量项目,总计 0 23.612 10.606
融资活动产生的现金 48.016 436.145 41.907 10.204 6.998
股票的发行(报废),净额 1.417 436.145 36.962 0.332 1.348
债务的发行(退还),净额 46.599 0 4.945 9.872 5.65
现金净变化 -90.433 391.542 34.644 11.578 16.893
已付现金利息 0.684 0.751
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -51.169 -203.674 -165.011 -110.927 -56.346
Cash From Operating Activities -49.039 -135.043 -92.546 -75.893 -42.95
Cash From Operating Activities 0.224 1.193 0.883 0.594 0.307
Non-Cash Items 8.516 36.205 27.281 19.773 10.995
Cash Interest Paid 0.169 0.684 0.173 0.173 0.169
Changes in Working Capital -6.61 31.233 44.301 14.667 2.094
Cash From Investing Activities -2.111 -3.406 -2.288 -0.522 -0.118
Capital Expenditures -2.111 -3.406 -2.288 -0.522 -0.118
Cash From Financing Activities 0.336 48.016 47.786 47.094 47.012
Issuance (Retirement) of Stock, Net 0.336 1.417 1.187 0.495 0.413
Issuance (Retirement) of Debt, Net 0 46.599 46.599 46.599 46.599
Net Change in Cash -50.814 -90.433 -47.048 -29.321 3.944
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Federated Hermes Global Investment Management Corp. Investment Advisor/Hedge Fund 16.0026 4239554 672057 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 8.5225 2257846 -472616 2022-12-31 LOW
ARK Investment Management LLC Investment Advisor 7.5961 2012429 -169274 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2255 1649315 32754 2022-12-31 LOW
Payne (Joseph E) Individual Investor 5.5868 1480097 5000 2022-11-23 LOW
Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 5.4696 1449060 -10355 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.4637 1447503 113607 2022-12-31 LOW
Ultragenyx Pharmaceutical Inc Corporation 4.5295 1200000 -200000 2021-10-25 LOW
Balyasny Asset Management LP Hedge Fund 3.7906 1004235 664852 2022-12-31 HIGH
Fidelity Management & Research Company LLC Investment Advisor 3.4358 910243 -44082 2022-12-31 LOW
Woodline Partners LP Hedge Fund 2.8397 752331 -125193 2022-12-31 HIGH
BofA Global Research (US) Research Firm 2.5892 685954 577968 2022-12-31 LOW
Chivukula (Padmanabh) Individual Investor 2.2249 589448 -5000 2023-03-06 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6983 449939 33148 2022-12-31 LOW
JPMorgan Asset Management U.K. Limited Investment Advisor/Hedge Fund 1.2402 328567 -2938 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 1.1449 303306 112903 2022-12-31 HIGH
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.1432 302861 159743 2022-12-31 LOW
Sassine (Andy H) Individual Investor 1.0354 274313 1068 2022-08-15 LOW
Goldman Sachs & Company, Inc. Research Firm 0.9932 263138 -35493 2022-12-31 MED
Rafferty Asset Management LLC Investment Advisor/Hedge Fund 0.7899 209254 -51726 2022-12-31 MED

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Arcturus Therapeutics Holdings Inc. Company profile

关于 Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc.是一家处于后期阶段的全球临床信使核糖核酸(mRNA)药物公司。 公司专注于传染病疫苗的开发以及肝脏和呼吸道罕见疾病的重要机会。 除mRNA平台外,公司的脂质纳米粒子(LNP)递送系统LUNAR有可能实现多种核酸药物,其自我复制mRNA技术(Self-Transcribing and Replicating RNA(STARR),技术)有可能在较低剂量水平上提供更持久的RNA和持续蛋白表达。 该公司使用STARR技术处于开发阶段的产品是ARCT-021、ARCT-154和ARCT-165。 其基于STARR技术平台的COVID-19候选疫苗ARCT-021正在进行II期临床试验。 其LUNAR-FLU疫苗包括肝脏特许经营ARCT-810(LUNAR-OTC)和肺部特许经营ARCT-032(LUNAR-CF)。

Industry: Biotechnology & Medical Research (NEC)

10628 Science Center Dr Ste 250
SAN DIEGO
CALIFORNIA 92121-1132
US

收入报表

  • Annual
  • Quarterly

人们也观看

XRP/USD

0.45 Price
+4.870% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00346

US100

12,798.80 Price
+0.420% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 3.0

Gold

1,978.85 Price
-0.760% 1D Chg, %
多头隔夜费 -0.0179%
空头隔夜费 0.0097%
隔夜费时间 21:00 (UTC)
价差 0.30

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多头隔夜费 -0.0194%
空头隔夜费 -0.0025%
隔夜费时间 21:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易